IntrinsicIntrinsic
← Scroll for more →

Financial Statements — HTFL

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025
Cash & Equivalents0.030.020.290.08
Short-term Investments0.130.14----
Accounts Receivable0.040.040.030.03
Total Current Assets0.220.210.330.12
Property, Plant & Equipment0.010.010.010.01
Total Non-current Assets*0.120.130.040.04
Total Assets0.340.340.360.16
Accounts Payable0.000.010.000.00
Total Current Liabilities0.040.040.040.03
Total Non-current Liabilities*0.020.020.070.25
Total Liabilities0.060.060.110.29
Retained Earnings(1.13)(1.12)(1.06)(1.01)
Total Stockholder Equity0.280.290.25(0.89)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Total Revenue64.0852.5949.1346.2843.42
Cost of Revenue10.8910.4210.0710.8610.65
Gross Profit53.1942.1639.0635.4232.78
Research & Development26.2621.6218.6717.3015.03
Selling, General & Admin14.2512.6138.1533.2231.46
Total Operating Expenses71.0971.6756.8150.5146.49
Operating Income(17.90)(29.50)(17.75)(15.10)(13.71)
Pretax Income(15.72)(27.36)(24.56)(50.82)(9.14)
Tax Provision0.020.02(0.16)0.030.06
Net Income(15.74)(27.38)(24.39)(50.85)(9.20)
Basic EPS(0.18)(0.32)1.30(1.04)(1.46)
Diluted EPS(0.18)(0.32)1.30(1.04)(1.46)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Operating Cash Flow(8.58)(30.10)(10.60)(2.96)(40.47)
Capital Expenditures1.921.891.901.241.89
Free Cash Flow*(10.50)(31.99)(12.49)(4.19)(42.36)
Investing Cash Flow21.22(1.43)(235.44)(1.24)(1.89)
Financing Cash Flow2.056.16(0.05)214.9471.15
← Scroll for more columns →

* Derived from reported values